Aims: Focus of pacemaker therapy is shifting from right ventricular (RV) apex pacing (RVAP) and biventricular pacing (BiVP) to conduction system pacing. Direct comparison between the different pacing modalities and their consequences to cardiac pump function is difficult, due to the practical implications and confounding variables. Computational modelling and simulation provide the opportunity to compare electrical, mechanical, and haemodynamic consequences in the same virtual heart.Methods and results: Using the same single cardiac geometry, electrical activation maps following the different pacing strategies were calculated using an Eikonal model on a three-dimensional geometry, which were then used as input for a lumped mechanical and haemodynamic model (CircAdapt). We then compared simulated strain, regional myocardial work, and haemodynamic function for each pacing strategy. Selective His-bundle pacing (HBP) best replicated physiological electrical activation and led to the most homogeneous mechanical behaviour. Selective left bundle branch (LBB) pacing led to good left ventricular (LV) function but significantly increased RV load. RV activation times were reduced in non-selective LBB pacing (nsLBBP), reducing RV load but increasing heterogeneity in LV contraction. LV septal pacing led to a slower LV and more heterogeneous LV activation than nsLBBP, while RV activation was similar. BiVP led to a synchronous LV–RV, but resulted in a heterogeneous contraction. RVAP led to the slowest and most heterogeneous contraction. Haemodynamic differences were small compared to differences in local wall behaviour.Conclusion: Using a computational modelling framework, we investigated the mechanical and haemodynamic outcome of the prevailing pacing strategies in hearts with normal electrical and mechanical function. For this class of patients, nsLBBP was the best compromise between LV and RV function if HBP is not possible.
1 August 2020 in International Journal of Cardiology
Patient outcome in Trans‐Aortic Valve Implantation (TAVI) therapy partly relies on a patient’s haemodynamic properties that cannot be determined from current diagnostic methods alone. In this study, we predict changes in haemodynamic parameters(as apart of patient outcome) after valve replacement treatment in aortic stenosis patients. A framework to incorporate uncertainty in patient‐specific model predictions for decision support is presented. A0Dlumped parameter mode lincluding the left ventricle, astenotic valve and systemic circulatory system has been developed, based on models published earlier. The Unscented Kalman Filter (UKF)isused to optimize model input parameters to fit measured data pre‐intervention. After optimization, the valve treatment is simulated by significantly reducing valve resistance. Uncertain model parameters are then propagated using a polynomial chaos expansion approach. To test the proposed framework, three in silico test cases are developed with clinically feasible measurements. Quality and availability of simulated measured patient data are decreased in each case. The UKF approach is compared to a Monte Carlo Markov Chain (MCMC) approach, a well‐known approach in modelling predictions with uncertainty. Both methods show increased confidence intervals as measurement quality decreases. By considering three in silico test‐cases we incorporate optimization uncertainty in model predictions and is faster and the MCMC approach, although it is more sensitive to noise in flow measurements. To conclude, this work shows that the proposed framework is ready to be applied to real patient data.
Current aortic stenosis severity grading is based mainly on the local properties of the stenotic valve, such as pressure gradient or jet velocity. Success rates of valve replacement therapy are still suboptimal, so alternative grading of AS should be investigated. We suggest the efficiency of power transfer from the left ventricle to the aorta, as it takes into account heart, valve and circulatory system. Left ventricular and circulatory power were estimated using a 0D model, which was optimised to patient data: left ventricular and aortic pressure, aortic flow and diastolic left ventricular volume. Optimisation was performed using a data assimilation method. These data were available in rest as well as chemically induced exercise for twelve patients. Using this limited data set, we showed that aortic valve efficiency is highly heterogeneous between patients, but also often dependent on the haemodynamic load. This indicates that power transfer efficiency is a highly interesting metric for further research in aortic stenosis.
31 March 2026 in International Journal for Numerical Methods in Biomedical Engineering
Aortic stenosis (AS) severity is typically assessed by measuring pressure drop across the aortic valve in rest. However, this flow‐dependent metric is influenced by patients' cardiac function, complicating clinical decision‐making on valve replacement. Moreover, assessment during rest does not reflect valvular dynamics under higher flow rates (e.g., during exercise), and may underestimate severity in moderate AS patients. Patient‐specific Fluid–Structure Interaction (FSI) modelling offers a promising, non‐invasive method to simulate valve dynamics under varying conditions, independent of pressure exerted by the left ventricle. Therefore, this study aimed to experimentally verify an aortic stenosis FSI model using a patient‐specific aortic valve geometry, including calcifications, across flow conditions ranging from rest to exercise. To achieve this goal, in vitro experiments were conducted using a mock‐loop circulatory system with patient‐specific silicone rubber valve models, both calcified and non‐calcified. These experiments were replicated in FSI simulations. Overall, good agreement was observed between simulated and experimental results for the non‐calcified valve in terms of mean transvalvular flow (5% error on average) and aortic valve area (AVA) (10% error on average). Discrepancies were more pronounced in the calcified valve due to added complexity and uncertainty introduced by calcifications (8% and 7% error on average for mean transvalvular flow and AVA, respectively). For clinical implementation, two key challenges remain: (1) developing efficient and reliable methods to estimate valve leaflet material properties and pre‐stress, and (2) verifying the model against a broader range of in vitro data, followed by validating it against real, clinical data. Despite the remaining challenges, this study demonstrated the feasibility of using FSI models as a complementary, non‐invasive tool to assess AS severity and support clinical decision‐making on valve replacement.